|
|
.
See Category: Congenital malformations, deformations and chromosomal abnormalities
ICD-10 (CM) Code and Descriptor
|
Q51.9 |
Congenital malformation of uterus and cervix, unspecified
Diagnosis Valid for Female Patient Only
|
Q519 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 10 |
ICD10
Position 11 |
| 24.75%
|
26.73%
|
19.31%
|
8.91%
|
6.93%
|
1.49%
|
4.95%
|
4.46%
|
0.99%
|
0.50%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Q51.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
76830
|
TRANSVAGINAL US NON-OB |
14
|
14
|
|
76856
|
US EXAM PELVIC COMPLETE |
11
|
11
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
8
|
8
|
|
A9585
|
GADOBUTROL INJECTION |
5
|
341
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
4
|
5
|
|
72197
|
MRI PELVIS W/O & W/DYE |
4
|
4
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
3
|
3
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
3
|
3
|
|
G1004
|
CDSM NDSC |
3
|
3
|
|
J1170
|
HYDROMORPHONE INJECTION |
2
|
4
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
2
|
2
|
|
G0467
|
FQHC VISIT, ESTAB PT |
2
|
2
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
2
|
3
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2
|
8
|
|
87624
|
HPV HI-RISK TYP POOLED RSLT |
2
|
2
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
2
|
2
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1
|
8
|
|
58555
|
HYSTEROSCOPY DX SEP PROC |
1
|
1
|
|
J1885
|
KETOROLAC TROMETHAMINE INJ |
1
|
2
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1
|
20
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Q51.9 related to the following DRG Codes:
742-743
760-761
|
